The major drivers of liver cancer are largely preventable – yet public awareness of the disease remains low.
Articles on Viral hepatitis
Displaying all articles
CC BY-NC-ND10.5 MB (download)
New direct-acting antiviral drugs would work successfully in countries where numerous different strains of hepatitis C are found.
HIV/AIDS receives more funding than hepatitis, which is responsible for more deaths.
Babies in Australia have been vaccinated against hepatitis B since May 2000, but 240,000 Australians still live with the disease.
When day zero arrives in Cape Town, the routine surveillance systems that monitor disease outbreaks will be enhanced to pick up new diseases.
Top contributors
-
Public Health Registrar in the Division of Public Health Medicine, University of Cape Town
-
Distinguished Professor, Division of Family Medicine and Primary Care, Stellenbosch University
-
Public Health Specialist in the Division of Health Systems and Public Health,, Stellenbosch University
-
Senior Medical Scientist at VIDRL, Royal Melbourne Hospital, The Peter Doherty Institute for Infection and Immunity
-
Research Associate (Centre for Virus Research), University of Glasgow
-
Obstetrician and Gynecologist, Mbarara University of Science and Technology
-
Associate Research Scientist, African Population and Health Research Center
-
Medical Scientist, Melbourne Health
-
Professor of Viral Hepatitis, University of Glasgow
-
Senior Clinical Lecturer & Consultant Hepatologist, Group Leader Barts Cancer Institute, Queen Mary University of London